Brief: Nexstim Reports Treatment Outcomes Of Over 400 MDD Patients
Oct 11 (Reuters) - Nexstim Oyj NXTMH.HE :
* REPORTS TREATMENT OUTCOMES OF OVER 400 MDD PATIENTS IN
PATIENT
REGISTRY
* OF 403 PATIENTS 49.6% WERE IN REMISSION AT END OF
TREATMENT,
76.2% HAD OBTAINED CLINICAL RESPONSE
Source text for Eikon: ID:nGNE4nKtL3
Further company coverage: NXTMH.HE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Nexstim Oyj
See all newsBrief: Nexstim Receives Order For NBS 6 System From Finnish Hospital
Brief: Nexstim Gets Order for NBS 6 System From European Hospital
Brief: US University Customer Purchases Nexstim NBS 6 For Research Purposes
Brief: Nexstim Gets NBS 6 System Order For European Hospital
Brief: Nexstim Gets Order From New U.S. Customer